$VRX Valeant Pharmaceuticals International, Inc. $
Post# of 2218
Valeant Pharmaceuticals International, Inc. (VRX) is confirmed to report earnings at approximately 7:00 AM ET on Tuesday, May 9, 2017. The consensus earnings estimate is $0.96 per share on revenue of $2.16 billion and the Earnings Whisper ® number is $0.96 per share. Investor sentiment going into the company's earnings release has 43% expecting an earnings beat. Consensus estimates are for earnings to decline year-over-year by 24.41% with revenue decreasing by 8.92%. Short interest has increased by 49.1% since the company's last earnings release while the stock has drifted lower by 37.7% from its open following the earnings release to be 45.1% below its 200 day moving average of $18.35. Overall earnings estimates have been revised lower since the company's last earnings release. On Tuesday, May 2, 2017 there was some notable buying of 7,774 contracts of the $10.00 call expiring on Friday, July 21, 2017. Option traders are pricing in a 12.9% move on earnings and the stock has averaged a 22.5% move in recent quarters.
Walt Disney Co $111.99